23andMe CEO Proposes to Take Company Private After Shares Plunge to Over 95% After its shares nosedived to more than 95%, 23andMe CEO Anne Wojcicki wants the firm to go private, citing that she "wishes to maintain control" of the company. by Joseph Henry
Tech 23andMe Blames Victims on Recent Data Breach Incident Concerning 6.9 Million Users by Aldohn Domingo
Tech Genetic Testing Firm 23andMe Confirms Hackers Accessed 14,000 Customer Accounts, Including Ancestry Data by Jace Dela Cruz
Tech DNA Testing Companies Adopt 2-Factor Authentication in Response to 23andMe Data Breach by Quincy Jon
Tech 23andMe Hit By Another Data Breach as Hacker Leaks Millions of Users' Stolen Information by Quincy Jon
Health Prostate Cancer Risk Test Gets FDA Clearance; 23andMe Reports New Test for Mutation by Isaiah Richard
Health 23andMe CEO Compares Complicated Genetic Risk Reports To Simple At-Home Pregnancy Test by Jean-Pierre Chigne
Tech April Fool's Lexus Genetic Select Lets You Start Your Car By Licking The Steering Wheel by John Diente
Health 23andMe Genetic Testing Kit Gets FDA Approval: Things To Know Before Using DNA Test For Disease Risk by Allan Adamson
Science Genetic Testing Company 23andMe Becomes First Direct-To-Consumer Service Approved By FDA by J.E. Reich
Healthy Living/Wellness FDA Softens Stance On 23andMe Genetic Testing For Inheritable Diseases by Dianne Depra
Healthy Living/Wellness Is Motion Sickness Genetic? 23andMe Isolates Responsible Gene by James Maynard
Healthy Living/Wellness 23andMe to Sell DNA Data of Parkinson's Customers to Genentech for $60 Million by Rhodi Lee
Healthy Living/Wellness 23andMe bows to FDA pressure, says will stop issuing health reports by Sumit Passary
Business Tech 23andMe, hit with class action lawsuit, has stopped marketing DNA test kits by Anu Passary